Rheumatic Heart Disease News and Research

RSS

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.

26 Sep 2011

Insight into how bacterial toxins cause human diseases may help improve treatment

A better understanding of how bacterial toxins cause common human diseases may lead to their improved treatment and prevention according to a paper just published by Irish and US scientists in Nature Reviews Microbiology.

25 Aug 2011

Medtronic to make nearly $4 million in 2011 to address non-communicable diseases

In its continued commitment to reduce the global burden of non-communicable diseases, Medtronic, Inc. today announced it will make nearly $4 million in Medtronic Foundation grants in 2011 to international organizations specifically to address diseases such as diabetes and heart disease in developing countries.

3 Mar 2011

HHS partners with PEPFAR to invest $130M for African medical education

The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief with a plan to invest $130 million over five years to transform African medical education and dramatically increase the number of health care workers.

7 Oct 2010

New approach to evaluate risk of cardiovascular disease

A new approach to evaluating a person's risk of cardiovascular disease, stroke, high blood pressure, or heart failure is reported this month in the International Journal of Data Mining, Modelling and Management. The technique uses fuzzy logic to teach a neural network computer program to analyze patient data and spot correlations that can be translated into a risk factor for an individual.

16 Sep 2010

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.

29 May 2010

Environment plays role in hypoplastic left heart syndrome

A congenital heart disease that often leads to death in newborns is significantly more common during the summer, leading researchers to believe that the environment, and not just genes that affect the heart, may play a role in causing "mini-epidemics" of this disease.

30 Mar 2009

Help for children with rheumatic heart disease

These bacteria carry a special protein sequence, the so-called PARF motif, on their surface.

2 Mar 2009

Combining medical knowledge to save lives

Cardiovascular disease (CVD) is the biggest killer among chronic diseases, claiming 17 million lives globally every year. Yet doctors can only attribute 50% of cardiovascular diseases to known risk factors.

9 Jul 2008

Traffic pollution linked to thousands of deaths from pneumonia

British researchers are suggesting that high levels of pollution may have contributed to the deaths in recent years of thousands of people in England from pneumonia.

15 Apr 2008

Antibiotics before dental procedures may do more harm than good

Taking a precautionary antibiotic before a trip to the dentist isn't necessary for most people, and in fact, might create more harm than good, according to updated recommendations from the American Heart Association.

20 Apr 2007

Fewer heart patients need antibiotics before dental procedures to prevent infective endocarditis

Based on a review of new and existing scientific evidence, most dental patients with heart disease do not need antibiotics before dental procedures to prevent infective endocarditis (IE), a rare, but life-threatening heart infection.

20 Apr 2007

Quick diagnosis test for streptococcal strains

A streptococcal infection may initially cause nothing more than a relatively harmless sore throat. It can, however, also lead to potentially fatal disease or lifelong disability.

8 Mar 2007

Genetic link suggested in deaths from cardiac valve diseases

Deaths from cardiac valve diseases appear to run in families, suggesting a significant genetic component, according to a study published in Circulation: Journal of the American Heart Association.

2 Nov 2004

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

QIMR researchers have received a 5 year grant from the National Institutes of Health in the USA to develop a vaccine against Group A streptococcus. This extremely prestigious grant makes QIMR one of the most successful recipients of NIH funding in Australia.

18 Oct 2004

Australian researchers are working on a vaccine to prevent rheumatic fever and rheumatic heart disease

The Queensland Institute of Medical Research (QIMR) Australia, is working on a vaccine to prevent rheumatic fever (RF) and rheumatic heart disease (RHD). Rheumatic fever and rheumatic heart disease are a secondary complication of a bacterial infection.

12 May 2004